FDA Considers Approval of Advanced Sunscreen Ingredient Bemotrizinol
The United States may soon experience a significant shift in sunscreen regulations, as the Food and Drug Administration (FDA) is evaluating the approval of bemotrizinol, a highly effective ultraviolet (UV) filter already in use internationally. Bemotrizinol offers broad-spectrum protection against both UVA and UVB rays, with exceptional photostability, meaning it remains effective even after prolonged sun exposure. This development is seen as a positive step in combating skin cancer, the most common cancer in the U.S., affecting one in five Americans during their lifetime. Dermatologists have praised the potential approval, noting that it could lead to more effective, stable, and cosmetically appealing sunscreen options for consumers. Currently, U.S. sunscreens lag behind international standards due to stringent FDA regulations, which classify sunscreen ingredients as over-the-counter drugs requiring extensive safety and efficacy data. If approved, bemotrizinol could enhance sunscreen formulations, making ... 
